CIK 0001642380 · Non-accelerated filer<br>Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 271041563
- Phone
- 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-14 | PURA VIDA INVESTMENTS, LLC 10% owner | Purchase · Warrant to purchase common stock | +958,209 | 958,209 | ||
| 2022-04-14 | PURA VIDA INVESTMENTS, LLC 10% owner | Purchase | +1,665,898 | $1.33 | $2.2M | 7,350,447 |
| 2022-04-14 | PURA VIDA INVESTMENTS, LLC 10% owner | Purchase | +30,790 | $1.23 | $38K | 7,381,237 |
| 2022-04-14 | PURA VIDA INVESTMENTS, LLC 10% owner | Purchase | +92,370 | $1.26 | $116K | 7,473,607 |
| 2022-04-14 | PURA VIDA INVESTMENTS, LLC 10% owner | Purchase | +1,916,419 | $1.33 | $2.6M | 8,455,823 |
| 2022-04-14 | PURA VIDA INVESTMENTS, LLC 10% owner | Purchase | +19,210 | $1.23 | $24K | 8,475,033 |
| 2022-04-14 | PURA VIDA INVESTMENTS, LLC 10% owner | Purchase | +57,630 | $1.26 | $73K | 8,532,663 |
| 2022-04-14 | PURA VIDA INVESTMENTS, LLC 10% owner | Purchase | +767,952 | $1.33 | $1.0M | 767,952 |
| 2022-04-14 | PURA VIDA INVESTMENTS, LLC 10% owner | Purchase | +1,381,438 | $1.33 | $1.8M | 1,381,438 |
| 2022-04-14 | PURA VIDA INVESTMENTS, LLC 10% owner | Purchase · Warrant to purchase common stock | +832,949 | 832,949 | ||
| 2022-04-14 | PURA VIDA INVESTMENTS, LLC 10% owner | Purchase · Warrant to purchase common stock | +383,976 | 383,976 | ||
| 2022-04-14 | PURA VIDA INVESTMENTS, LLC 10% owner | Purchase · Warrant to purchase common stock | +690,719 | 690,719 | ||
| 2022-04-14 | PURA VIDA INVESTMENTS, LLC 10% owner | Purchase · Warrant to purchase common stock | +958,209 | 958,209 | ||
| 2022-04-14 | BROADWOOD PARTNERS, L.P. 10% owner | Purchase | +6,003,752 | $1.33 | $8.0M | 23,353,697 |
| 2022-04-14 | BROADWOOD PARTNERS, L.P. 10% owner | Purchase | +0 | 23,353,697 | ||
| 2022-04-14 | BROADWOOD PARTNERS, L.P. 10% owner | Grant or award · Warrant to Purchase Common Stock | +6,003,752 | 6,003,752 | ||
| 2022-04-14 | BROADWOOD PARTNERS, L.P. 10% owner | Grant or award · Warrant to Purchase Common Stock | +0 | 6,003,752 | ||
| 2022-04-13 | BROADWOOD PARTNERS, L.P. 10% owner | Grant or award · Series A Convertible Preferred Stock | +5,882.35 | 5,882.35 | ||
| 2022-04-13 | BROADWOOD PARTNERS, L.P. 10% owner | Grant or award · Series A Convertible Preferred Stock | +0 | 5,882.35 | ||
| 2022-03-25 | Ross Douglas T. Chief Scientific Officer | Purchase | +15,000 | $1.40 | $21K | 20,317 |
Page 11 of 12 · 222 trades